Insider Transactions in Q2 2022 at Caribou Biosciences, Inc. (CRBU)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 13
2022
|
Steven Kanner Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
74,420
+10.37%
|
$148,840
$2.25 P/Share
|
|
May 09
2022
|
Rachel E. Haurwitz President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+33.33%
|
$20,000
$2.96 P/Share
|
|
May 05
2022
|
Ryan Fischesser VP of Finance and Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
2,274
+0.98%
|
$6,822
$3.4 P/Share
|